Press Release

United Kingdom Colorectal Cancer Therapeutics Market to be Dominated by Immunotherapy Segment through 2028

Increasing prevalence of colorectal cancer and changing lifestyle are expected to drive the United Kingdom Colorectal Cancer Therapeutics Market in the forecast period, 2024-2028.

 

According to TechSci Research report, “United Kingdom Colorectal Cancer Therapeutics Market – By Region, Competition Forecast and Opportunities, 2018-2028,” the United Kingdom Colorectal Cancer Therapeutics Market is projected to experience significant growth during the forecast period, 2024-2028. In the last decade, there has been a noticeable increase in public awareness campaigns aimed at promoting colorectal cancer screening and early detection. These initiatives have effectively educated the general population about the importance of regular screenings, such as colonoscopies, fecal occult blood tests, and sigmoidoscopies. Early detection of the disease leads to improved treatment outcomes and higher survival rates. Furthermore, advancements in diagnostic techniques have enhanced the accuracy and effectiveness of colorectal cancer screening. Non-invasive tests, like DNA-based stool tests, have gained popularity due to their convenience and ability to detect genetic mutations associated with colorectal cancer. Medical imaging technologies, such as computed tomography (CT) scans and magnetic resonance imaging (MRI), have also improved the ability to detect and stage colorectal cancer. The growing geriatric population in the United Kingdom is a key driver for the expansion of the colorectal cancer therapeutics market. The increasing prevalence of colorectal cancer among the elderly necessitates the development of innovative treatment options tailored to their specific needs. Another significant risk factor for colorectal cancer is obesity, which is linked to a sedentary lifestyle.

Surprisingly, this elevated risk is associated with increased calorie intake as well as visceral adipose tissue, a hormonally active subset of total body fat that can promote the growth of colorectal cancer through the secretion of proinflammatory cytokines, leading to inflammation in the colon and rectum, insulin resistance, and the modulation of metabolic enzymes like adiponectin or lectin. The rising prevalence of colorectal cancer has directly impacted the Colorectal Cancer Therapeutics Market in the United Kingdom. The demand for effective treatment options, coupled with advancements in precision medicine and immunotherapies, has driven the growth of this market. With advancements in surgical techniques, chemotherapy, targeted therapy, and immunotherapy, the healthcare industry is better equipped to address the challenges posed by this disease, thereby propelling the growth of the United Kingdom Colorectal Cancer Therapeutics Market during the projected period. However, challenges such as the high cost of innovative therapies, limited access to certain treatments, lack of skilled healthcare professionals, high expenses associated with personalized treatment regimens, treatment resistance, adverse effects, and disparities in healthcare provision may hinder the market's growth in the forecast period.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on United Kingdom Colorectal Cancer Therapeutics Market


 

The United Kingdom Colorectal Cancer Therapeutics Market is categorized by Drug Class, End User, and Region and Competitive Landscape.

Regarding Drug Class, the market is segmented into Chemotherapy, Immunotherapy, and Others. The immunotherapy segment is expected to experience growth during the forecast period. This is attributed to the favorable outcomes observed in patients with tumors that exhibit microsatellite instability or mutations impairing mismatch repair. The results of immunotherapy for colorectal cancer have been remarkable, which is anticipated to foster market expansion in the future.

Concerning End User, the market is divided into Hospitals, Clinics, and Others. The hospital segment is projected to witness growth in the forecast period. This can be attributed to the availability of advanced technologies, skilled healthcare staff, and comprehensive inpatient and outpatient medical facilities. These factors are expected to contribute to the market's growth in the future.


Major companies operating in the United Kingdom Colorectal Cancer Therapeutics Market are:

  • Novartis AG
  • Pfizer Inc
  • Eli Lilly & Company
  • Merck Co. & Inc.
  • GlaxoSmithKline, Plc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Sanofi S.A.
  • Roche Holding AG


Download Free Sample Report

Customers can also request 10% free customization in this report.

 

“The United Kingdom Colorectal Cancer Therapeutics Market is anticipated to experience significant growth in the upcoming years. This can be attributed to the increasing prevalence of colorectal cancer, combined with the growing awareness among the population regarding the causes, symptoms, and treatment of colorectal cancer within the country. Moreover, the market is witnessing substantial growth driven by the rising geriatric population and the subsequent demand for effective treatment options. Additionally, advancements in oncological technology have contributed to the increased demand for colorectal cancer therapeutics, which is expected to continue to grow through 2028.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“United Kingdom Colorectal Cancer Therapeutics Market By Drug Class (Chemotherapy, Immunotherapy, Others), By End User (Hospitals, Clinics, Others), By Region, Competition Forecast & Opportunities, 2018-2028F,” has evaluated the future growth potential of United Kingdom Colorectal Cancer Therapeutics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United Kingdom Colorectal Cancer Therapeutics Market.


Contact

Mr. Ken Mathews         

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656                                                     

Email: [email protected]               

Website: www.techsciresearch.com               

Relevant Reports

United Kingdom Colorectal Cancer Therapeutics Market By Drug Class (Chemotherapy, Immunotherapy, Others), By End User (Hospitals, Clinics, Others), By Region, Competition Forecast & Opportunities, 2018-2028F

Healthcare | Oct, 2023

Increasing prevalence of colorectal cancer and changing lifestyle are expected to drive the United Kingdom Colorectal Cancer Therapeutics Market in the forecast period, 2024-2028.

Relevant News